Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis

International Journal of Cancer

Volumn 140, Issue 2, 2017, Pages 322-328

  Taylor, Amy E ^a   Martin, Richard M ^a,b   Geybels, Milan S ^c   Stanford, Janet L ^c,d   Shui, Irene ^c   Eeles, Rosalind ^e,f   Easton, Doug ^g   Kote Jarai, Zsofia ^e   Amin Al Olama, Ali ^g   Benlloch, Sara ^g   Muir, Kenneth ^h   Giles, Graham G ^i,j   Wiklund, Fredrik ^k   Gronberg, Henrik ^k   Haiman, Christopher A ^l   Schleutker, Johanna ^m,n   Nordestgaard, Børge G ^o   Travis, Ruth C ^p   Neal, David ^q   Pashayan, Nora ^j,r   Khaw, Kay Tee ^s   Blot, William ^t   Thibodeau, Stephen ^u   Maier, Christiane ^v   Kibel, Adam S ^w,x   Cybulski, Cezary ^y   Cannon Albright, Lisa ^z   Brenner, Hermann ^aa   Park, Jong ^ab   Kaneva, Radka ^ac   Batra, Jyotsna ^ad   Teixeira, Manuel R ^ae,af   Pandha, Hardev ^ag   Donovan, Jenny ^a   Munafò, Marcus R ^a   more..

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c USA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁱ CANCER EPIDEMIOLOGY CENTRE   (Australia)

^j UNIVERSITY OF MELBOURNE   (Australia)

^k KAROLINSKA INSTITUTE   (Sweden)

^l UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^m UNIVERSITY OF TURKU   (Finland)

ⁿ TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^o GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^p UNIVERSITY OF OXFORD   (United Kingdom)

^q UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^r UNIVERSITY COLLEGE LONDON   (United Kingdom)

^s UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^t INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^u MAYO CLINIC   (United States)

^v UNIVERSITY HOSPITAL ULM   (Germany)

^w BRIGHAM AND WOMEN S HOSPITAL   (United States)

^x WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^y POMERANIAN MEDICAL UNIVERSITY   (Poland)

^z UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^aa GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ab H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^ac MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^ad QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^ae PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^af UNIVERSITY OF PORTO   (Portugal)

^ag UNIVERSITY OF SURREY   (United Kingdom)

more..

Author keywords

coffee; Mendelian randomization; prostate cancer

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CAUSE OF DEATH; COFFEE; CONTROLLED STUDY; CORRELATION ANALYSIS; EUROPEAN; GENETIC RISK; GENETIC VARIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENDELIAN RANDOMIZATION ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; ADVERSE EFFECTS; DISEASE COURSE; GENETICS; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; RISK FACTOR;

COFFEE;

AGED; ALLELES; COFFEE; DISEASE PROGRESSION; GENETIC VARIATION; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84995982193     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30462     Document Type: Article

References (25)

1. Cao S, Liu L, Yin X, et al. Coffee consumption and risk of prostate cancer: a meta-analysis of prospective cohort studies. Carcinogenesis 2014;35:256–61.
2. Lu Y, Zhai L, Zeng J, et al. Coffee consumption and prostate cancer risk: an updated meta-analysis. Cancer Causes Control 2014;25:591–604.
3. Wilson KM, Balter K, Moller E, et al. Coffee and risk of prostate cancer incidence and mortality in the Cancer of the Prostate in Sweden Study. Cancer Causes Control 2013;24:1575–81.
4. Shafique K, McLoone P, Qureshi K, et al. Coffee consumption and prostate cancer risk: further evidence for inverse relationship. Nutr J 2012;11:42.
5. Wilson KM, Kasperzyk JL, Rider JR, et al. Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst 2011;103:876–84.
6. Discacciati A, Orsini N, Wolk A. Coffee consumption and risk of nonaggressive, aggressive and fatal prostate cancer–a dose-response meta-analysis. Ann Oncol 2014;25:584–91.
7. Jacobsen BK, Bjelke E, Kvale G, et al. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 1986;76:823–31.
8. Bosire C, Stampfer MJ, Subar AF, et al. Coffee consumption and the risk of overall and fatal prostate cancer in the NIH-AARP Diet and Health Study. Cancer Causes Control 2013;24:1527–34.
9. Tunnicliffe JM, Shearer J. Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 2008;33:1290–300.
10. McMahon G, Taylor AE, Davey Smith G, et al. Phenotype Refinement Strengthens the Association of AHR and CYP1A1 Genotype with Caffeine Consumption. PloS One 2014;9:e103448
11. Davey Smith G, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003;32:1–22.
12. Cornelis MC, Monda KL, Yu K, et al. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet 2011;7:e1002033.
13. Coffee and Caffeine Genetics Consortium, Cornelis MC, Byrne EM, et al. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry 2015;20:647–56
14. Amin N, Byrne E, Johnson J, et al. Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Mol Psychiatry 2012;17:1116–29.
15. Hukkanen J, Jacob P, III, Peng M, et al. Effect of nicotine on cytochrome P450 1A2 activity. Br J Clin Pharmacol 2011;72:836–8.
16. Shin SY, Fauman EB, Petersen AK, et al. An atlas of genetic influences on human blood metabolites. Nat Genet 2014;46:543–50.
17. Kote-Jarai Z, Easton DF, Stanford JL, et al. Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev 2008;17:2052–61.
18. Eeles RA, Olama AA, Benlloch S, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013;45:385–91. 91e1-2.
19. Davies NM, Gaunt TR, Lewis SJ, et al. The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Cause Control 2015;26:1603–16.
20. Yu X, Bao Z, Zou J, et al. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 2011;11:96
21. Freedman ND, Park Y, Abnet CC, et al. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012;366:1891–904.
22. Heatherley SV, Mullings EL, Tidbury MA, et al. The dietary caffeine and health study: administration of a large postal survey in Bristol. Appetite 2006;47:257–79.
23. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009;41:677–87.
24. Burdett T, Hall PN, Hasting E, Hindorff LA, Junkins HA, Klemm AK, MacArthur J, Manolio TA, Morales J, Parkinson H, Welter D. The NHGRI-EBI Catalog of published genome-wide association studies. Available at: www.ebi.ac.uk/gwas. Accessed 01/04/2016, version v1.0.
25. Benowitz NL, Peng M, Jacob P, III. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism. Clin Pharmacol Ther 2003;74:468–74.